Eupraxia Pharmaceuticals Inc. Common Stock EPRX
$8.40
+12.00%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $18.00
- Implied Upside
- +114.3%
- Price Target Range
- $11.00 – $25.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-26 | OppenheimerJay Olson |
Initiates coverage on | Outperform | $17 |
| 2026-05-21 | StifelAnnabel Samimy |
Initiates coverage on | Buy | $25 |
| 2026-05-04 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $11 |
| 2026-04-22 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $11 |
| 2026-03-23 | William BlairLachlan Brown |
Initiates coverage on | Outperform | — |
| 2026-03-17 | HC Wainwright & Co.Brandon Folkes |
Maintains | Buy | $12 → $11 |
| 2026-01-15 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $11 → $19 |
| 2026-01-09 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $12 |
| 2025-08-20 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $12 |
| 2025-07-24 | Cantor FitzgeraldKristen Kluska |
Initiates coverage on | Overweight | $11 |
| 2025-06-26 | HC Wainwright & Co.Brandon Folkes |
Initiates coverage on | Buy | $12 |
| 2024-11-14 | Rodman & RenshawBrandon Folkes |
Initiates coverage on | Buy | $9 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $8.40
- Market Cap
- $555.02 million
- 52-Week Range
- $5.04 – $9.32
- Average Volume
- 484K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.